Literature DB >> 20164849

Self blood pressure monitoring: a worthy substitute for ambulatory blood pressure?

N McGowan1, P L Padfield.   

Abstract

The European Society of Hypertension (ESH), the American Heart Association (AHA) and the American Society of Hypertension (ASH) have published guidelines for self-monitoring of blood pressure (SBPM). We aimed to demonstrate the equivalence of SBPM with ambulatory blood pressure monitoring (ABPM) in the assessment of hypertension. A total of 87 consecutive subjects referred from primary care for standard ABPM underwent a 1-week period of SBPM, as defined by the ESH guidelines, either before or after ABPM. There was no difference in mean blood pressure (BP): SBPM 142/87 mm Hg, daytime average ABPM 141/86 mm Hg. The intra-class correlation coefficient was 0.72 and 0.89 for systolic and diastolic pressure, respectively. SBPM is concordant with ABPM in classifying subjects as hypertensive or normotensive in 87% of cases (κ=0.56). The coefficient of variation of SBPM compared with ABPM was 5%. In answer to a direct question 81% of subjects preferred SBPM to ABPM. The current self-monitoring schedule recommended by the ESH, AHA and ASH is valid. The mean BP obtained from SBPM is equivalent to awake-time BP on ABPM, the accepted reference standard for 'out of office' BP measurement. SBPM is simpler to carry out, preferred by patients and should be considered on a par with ABPM.

Entities:  

Mesh:

Year:  2010        PMID: 20164849     DOI: 10.1038/jhh.2010.15

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  9 in total

Review 1.  Home Blood Pressure Monitoring.

Authors:  Jacob George; Thomas MacDonald
Journal:  Eur Cardiol       Date:  2015-12

Review 2.  Home blood pressure monitoring: primary role in hypertension management.

Authors:  George S Stergiou; Anastasios Kollias; Marilena Zeniodi; Nikos Karpettas; Angeliki Ntineri
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

3.  Patients' preference for ambulatory versus home blood pressure monitoring.

Authors:  E G Nasothimiou; N Karpettas; M G Dafni; G S Stergiou
Journal:  J Hum Hypertens       Date:  2013-10-24       Impact factor: 3.012

4.  Acceptability and psychological impact of out-of-office monitoring to diagnose hypertension: an evaluation of survey data from primary care patients.

Authors:  Alice C Tompson; Alison M Ward; Richard J McManus; Rafael Perera; Matthew J Thompson; Carl J Heneghan; David Nunan
Journal:  Br J Gen Pract       Date:  2019-03-25       Impact factor: 5.386

5.  Agreement between attended home and ambulatory blood pressure measurements in adolescents with chronic kidney disease.

Authors:  Trevor W Glenn; Cyd K Eaton; Kevin J Psoter; Michelle N Eakin; Cozumel S Pruette; Kristin A Riekert; Tammy M Brady
Journal:  Pediatr Nephrol       Date:  2022-02-15       Impact factor: 3.651

6.  Patient experience of home and waiting room blood pressure measurement: a qualitative study of patients with recently diagnosed hypertension.

Authors:  Alice C Tompson; Claire L Schwartz; Susannah Fleming; Alison M Ward; Sheila M Greenfield; Sabrina Grant; Fd Richard Hobbs; Carl J Heneghan; Richard J McManus
Journal:  Br J Gen Pract       Date:  2018-10-22       Impact factor: 5.386

Review 7.  Monitoring of Treatment for Arterial Hypertension–The Role of Office, Home, and 24 h Ambulatory Blood Pressure Measurement.

Authors:  Thomas Mengden; Burkhard Weisser
Journal:  Dtsch Arztebl Int       Date:  2021-07-12       Impact factor: 5.594

8.  The case for home monitoring in hypertension.

Authors:  Paul L Padfield
Journal:  BMC Med       Date:  2010-09-27       Impact factor: 8.775

9.  Patients' and clinicians' views on the optimum schedules for self-monitoring of blood pressure: a qualitative focus group and interview study.

Authors:  Sabrina Grant; James A Hodgkinson; Siobhan L Milner; Una Martin; Alice Tompson; Fd Richard Hobbs; Jonathan Mant; Richard J McManus; Sheila M Greenfield
Journal:  Br J Gen Pract       Date:  2016-07-05       Impact factor: 5.386

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.